National Venture Capital Association
Trade association representing US venture capital industry
Based in DC
🤖
AI Overview
With $1.7M in lobbying spend across 28 quarterly filings, National Venture Capital Association is a significant lobbying presence. They deploy 31 individual lobbyists
$1.7M
Total Lobbying Spend
28
Quarterly Filings
1
Lobbying Firms Used
31
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $240K |
| 2020 | $180K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $120K |
| 2025 | $180K |
Lobbying Firms
MEHLMAN CONSULTING, INC.
What They Lobby For
- Policies to encourage and empower entrepreneurship, including streamlined regulations at the SEC. Capital markets reforms to encourage more U.S. IPO's. Volcker Rule, S. 2155 - The Economic Growth, Regulatory Relief and Consumer Protection Act, and Registered Investment Advisor rules. CFIUS reform and limited partners.
- Immigration reforms and cyber security.
- Health care reform; FDA approval paths.
- Provisions related to the International Entrepreneur Rule. Investor VISA program. Entrepreneur VISA program.
- Tax reform and treatment of carried interest; Section 382, R&D, NOLs; and Section 1202. Implementation of PL 115-97 (H.R. 1/tax reform).
- Implementation of PL 115-97 (H.R. 1/tax reform). Tax treatment of investment capital and start-up companies.
- Policies to encourage and empower entrepreneurship, including streamlined regulations at the SEC. Capital markets reforms to encourage more U.S. IPO's. Volcker Rule, S. 2155 - The Economic Growth, Regulatory Relief and Consumer Protection Act, and Registered Investment Advisor rules. H.R. 5841/S. 2987 - Foreign Investment Risk Review Modernization Act of 2018.
- Implementation of PL 115-97 (H.R. 1/tax reform). Tax treatment of investment capital and start-up companies. H.R. 6756 - American Innovation Act of 2018.
- Monitor implementation of FIRMMA and export controls; restrictions on limited partners.
- FDA approval paths. Health care reform. Drug pricing policy. Reimbursement policy.
Related Investigations
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.